AstraZeneca and DNDi to collaborate on drug screening for neglected tropical diseases

AstraZeneca and the Drugs for Neglected Diseases initiative today announce an agreement to collaborate on drug-compound screening for leishmaniasis, Chagas disease, and sleeping sickness, three neglected tropical diseases which together affect nearly 10 million people worldwide. Novel drug candidates to emerge from this collaboration will bolster the drug development pipeline for new medicines urgently needed by millions of patients. Read more